Denali Capital Acquisition Corp. (DECA)
Market Cap | 80.70M |
Revenue (ttm) | n/a |
Net Income (ttm) | -1.50M |
Shares Out | 7.11M |
EPS (ttm) | 0.31 |
PE Ratio | 36.61 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 14,899 |
Open | 11.30 |
Previous Close | 11.37 |
Day's Range | 11.05 - 11.37 |
52-Week Range | 4.05 - 14.10 |
Beta | 0.06 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | n/a |
About DECA
Denali Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. It intends to complete a business combination with companies primarily operating in the technology, consumer services, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York. [Read more]
Financial Performance
Financial StatementsNews
![](https://cdn.snapi.dev/images/v1/m/d/press19-2500656.jpg)
Correction: Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or the "Company") announced today that Denali and Longevity Biomedical, Inc. have mutually agreed ...
![](https://cdn.snapi.dev/images/v1/r/u/press8-2500379.jpg)
Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or the "Company") announced today that Denali and Longevity Biomedical, Inc. have mutually agreed ...
![](https://cdn.snapi.dev/images/v1/g/3/press12-2474422.jpg)
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
NEW YORK, NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the “Company”) announced today that an aggregate of $50,000 has been deposited into the Company'...
![](https://cdn.snapi.dev/images/v1/i/v/press18-2211831.jpg)
Denali Capital Acquisition Corp. Announces Postponement of Extraordinary General Meeting From Thursday, January 4, 2024 to Tuesday, January 9, 2024
NEW YORK , Dec. 29, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (Nasdaq: DECA) (the "Company") announced today that its previously announced extraordinary general meeting (the "Shareholder M...
![](https://cdn.snapi.dev/images/v1/z/n/press14-2099707.jpg)
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination
NEW YORK , Oct. 11, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that the Company's shareholders voted in favor of approving amendments to the C...
![](https://cdn.snapi.dev/images/v1/x/p/press7-1969597.jpg)
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business Combination
NEW YORK , July 13, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or the "Company") announced today that an aggregate of $825,000 has been deposited into the Company's...
![](https://cdn.snapi.dev/images/v1/g/6/press19-1963039.jpg)
Denali Capital Acquisition Corp. Announces Intention to Extend Deadline to Complete an Initial Business Combination
NEW YORK , July 7, 2023 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or the "Company") announced today that it intends to deposit into the Company's trust account an aggre...
![](https://cdn.snapi.dev/images/v1/p/r/press6-1394703.jpg)
Denali Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing May 31, 2022.
NEW YORK , May 26, 2022 /PRNewswire/ -- Denali Capital Acquisition Corp. (NASDAQ: DECAU) ("Denali" or the "Company") announced today that, commencing May 31, 2022, holders of units (the "Units") sold ...